{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:27:05Z","timestamp":1783549625964,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korean government (MSIT)","award":["NRF-2018R1A2A1A05018309"],"award-info":[{"award-number":["NRF-2018R1A2A1A05018309"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.rmed.2019.01.012","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T12:13:34Z","timestamp":1548850414000},"page":"37-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease"],"prefix":"10.1016","volume":"148","author":[{"given":"Seong Mi","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3233-450X","authenticated-orcid":false,"given":"Junsu","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Woo","family":"Jhun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4822-1772","authenticated-orcid":false,"given":"Kyeongman","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O Jung","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jae","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4756-3527","authenticated-orcid":false,"given":"Won-Jung","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2019.01.012_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-0038-1651491","article-title":"Epidemiology of nontuberculous mycobacteriosis","volume":"39","author":"Adjemian","year":"2018","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.01.012_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ccm.2014.10.002","article-title":"Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review","volume":"36","author":"Prevots","year":"2015","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.rmed.2019.01.012_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijid.2016.03.006","article-title":"Update on pulmonary disease due to non-tuberculous mycobacteria","volume":"45","author":"Stout","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.rmed.2019.01.012_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1513\/AnnalsATS.201607-573OC","article-title":"A laboratory-based analysis of nontuberculous mycobacterial lung disease in Japan from 2012 to 2013","volume":"14","author":"Morimoto","year":"2017","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.rmed.2019.01.012_bib5","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1183\/09031936.00149212","article-title":"The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study","volume":"42","author":"Hoefsloot","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2019.01.012_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.01.012_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4046\/trd.2016.79.2.74","article-title":"Diagnosis and treatment of nontuberculous mycobacterial lung disease: clinicians' perspectives","volume":"79","author":"Ryu","year":"2016","journal-title":"Tuberc. Respir. Dis. (Seoul)"},{"key":"10.1016\/j.rmed.2019.01.012_bib8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3346\/jkms.2016.31.5.649","article-title":"Diagnosis and treatment of nontuberculous mycobacterial lung disease","volume":"31","author":"Kwon","year":"2016","journal-title":"J. Kor. Med. Sci."},{"key":"10.1016\/j.rmed.2019.01.012_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1378\/chest.80.2.132","article-title":"Initial roentgenographic manifestations of pulmonary Mycobacterium tuberculosis, M. kansasii, and M. intracellularis infections","volume":"80","author":"Christensen","year":"1981","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2019.01.012_bib10","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/thx.51.12.1243","article-title":"Pulmonary Mycobacterium kansasii infection: comparison of radiological appearances with pulmonary tuberculosis","volume":"51","author":"Evans","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2019.01.012_bib11","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10096-007-0331-3","article-title":"Differentiation of Mycobacterium kansasii infection from Mycobacterium tuberculosis infection: comparison of clinical features, radiological appearance, and outcome","volume":"26","author":"Shitrit","year":"2007","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.rmed.2019.01.012_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139621","article-title":"Clinical significance of Mycobacterium kansasii isolates from respiratory specimens","volume":"10","author":"Moon","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.rmed.2019.01.012_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.rmed.2018.05.007","article-title":"Clinical, radiological and molecular features of Mycobacterium kansasii pulmonary disease","volume":"139","author":"Bakula","year":"2018","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2019.01.012_bib14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-0038-1660473","article-title":"Treatment of other nontuberculous mycobacteria","volume":"39","author":"Basille","year":"2018","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.01.012_bib15","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/clinids\/3.5.1028","article-title":"Chemotherapy for pulmonary disease due to Mycobacterium kansasii: efficacies of some individual drugs","volume":"3","author":"Ahn","year":"1981","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.rmed.2019.01.012_bib16","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/clinids\/3.5.1035","article-title":"Treatment of pulmonary disease due to Mycobacterium kansasii: recent experience with rifampin","volume":"3","author":"Pezzia","year":"1981","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.rmed.2019.01.012_bib17","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.3389\/fmicb.2018.02271","article-title":"Therapy for Mycobacterium kansasii infection: beyond 2018","volume":"9","author":"DeStefano","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.rmed.2019.01.012_bib18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jinf.2015.12.007","article-title":"The antimicrobial susceptibility of non-tuberculous mycobacteria","volume":"72","author":"Cowman","year":"2016","journal-title":"J. Infect."},{"key":"10.1016\/j.rmed.2019.01.012_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01788-17","article-title":"Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium kansasii","volume":"62","author":"Bakula","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rmed.2019.01.012_bib20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1586\/14787210.2013.830413","article-title":"Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence","volume":"11","author":"van Ingen","year":"2013","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.rmed.2019.01.012_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccm.2014.10.005","article-title":"Treatment of slowly growing mycobacteria","volume":"36","author":"Philley","year":"2015","journal-title":"Clin. Chest Med."},{"issue":"Suppl 2","key":"10.1016\/j.rmed.2019.01.012_bib22","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2017-210927","article-title":"British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)","volume":"72","author":"Haworth","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2019.01.012_bib23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1378\/chest.129.3.771","article-title":"Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome","volume":"129","author":"Shitrit","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2019.01.012_bib24","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.rmed.2008.05.004","article-title":"Clinical and radiological features of Mycobacterium kansasii infection and Mycobacterium simiae infection","volume":"102","author":"Shitrit","year":"2008","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2019.01.012_bib25","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.rmed.2012.06.023","article-title":"Clinical and radiological features of Mycobacterium kansasii and other NTM infections","volume":"106","author":"Matveychuk","year":"2012","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2019.01.012_bib26","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1086\/378742","article-title":"Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study","volume":"37","author":"Griffith","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.rmed.2019.01.012_bib27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.chest.2017.04.166","article-title":"Microbiological and clinical outcomes of treating non-Mycobacterium avium complex nontuberculous mycobacterial pulmonary disease: a systematic review and meta-analysis","volume":"152","author":"Diel","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2019.01.012_bib28","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3349\/ymj.2010.51.4.552","article-title":"Clinical characteristics and treatment outcomes of Mycobacterium kansasii lung disease in Korea","volume":"51","author":"Park","year":"2010","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.rmed.2019.01.012_bib29","doi-asserted-by":"crossref","first-page":"1602503","DOI":"10.1183\/13993003.02503-2016","article-title":"Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype","volume":"50","author":"Koh","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2019.01.012_bib30","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/ciw724","article-title":"Mycobacterial characteristics and treatment outcomes in Mycobacterium abscessus lung disease","volume":"64","author":"Koh","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.rmed.2019.01.012_bib31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.201408-1545OC","article-title":"Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease","volume":"191","author":"Jeong","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2019.01.012_bib32","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1378\/chest.13-2538","article-title":"Macrolide\/azalide therapy for nodular\/bronchiectatic Mycobacterium avium complex lung disease","volume":"146","author":"Wallace","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2019.01.012_bib33","doi-asserted-by":"crossref","first-page":"1800170","DOI":"10.1183\/13993003.00170-2018","article-title":"Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement","volume":"51","author":"van Ingen","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2019.01.012_bib34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1128\/AAC.04075-14","article-title":"Effect of rifampin and rifabutin on serum itraconazole levels in patients with chronic pulmonary aspergillosis and coexisting nontuberculous mycobacterial infection","volume":"59","author":"Moon","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rmed.2019.01.012_bib35","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jiac.2017.02.004","article-title":"Effect of a 150 mg dose of rifabutin on serum itraconazole levels in patients with coexisting chronic pulmonary aspergillosis and Mycobacterium avium complex lung disease","volume":"23","author":"Moon","year":"2017","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.rmed.2019.01.012_bib36","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1128\/AAC.36.9.2039","article-title":"In vitro susceptibility of Mycobacterium kansasii to clarithromycin","volume":"36","author":"Biehle","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rmed.2019.01.012_bib37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/jac\/47.4.417","article-title":"Treatment alternatives for Mycobacterium kansasii","volume":"47","author":"Graybill","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.rmed.2019.01.012_bib38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0962-8479(95)90550-2","article-title":"Treatment of pulmonary disease caused by Mycobacterium kansasii: results of 18 vs 12 months' chemotherapy, Tuber","volume":"76","author":"Sauret","year":"1995","journal-title":"Lung Dis"},{"key":"10.1016\/j.rmed.2019.01.012_bib39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1183\/09031936.00024008","article-title":"Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease","volume":"33","author":"Santin","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2019.01.012_bib40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1378\/chest.129.2.341","article-title":"Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea","volume":"129","author":"Koh","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2019.01.012_bib41","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.3346\/jkms.2018.33.e65","article-title":"Changing epidemiology of nontuberculous mycobacterial lung diseases in a tertiary referral hospital in Korea between 2001 and 2015","volume":"33","author":"Ko","year":"2018","journal-title":"J. Kor. Med. Sci."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119300289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611119300289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:45:09Z","timestamp":1760615109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611119300289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":41,"alternative-id":["S0954611119300289"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2019.01.012","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2019.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}